CYP1B1 copy number variation is not a major contributor to primary congenital glaucoma
Purpose: To evaluate the prevalence and the diagnostic utility of testing for CYP1B1 copy number variation (CNV) in primary congenital glaucoma (PCG) cases unexplained by CYP1B1 point mutations in The Australian and New Zealand Registry of Advanced Glaucoma.
Methods: In total, 50 PCG cases either heterozygous for disease-causing variants or with no CYP1B1 sequence variants were included in the study. CYP1B1 CNV was analyzed by Multiplex Ligation-dependent Probe Amplification (MLPA).
Results: No deletions or duplications were found in any of the cases.
Conclusion: This is the first study to report on CYP1B1 CNV in PCG cases. Our findings show that this mechanism is not a major contributor to the phenotype and is of limited diagnostic utility.
History
Publication title
Molecular VisionVolume
21Pagination
160-164ISSN
1090-0535Department/School
Menzies Institute for Medical ResearchPublisher
Molecular VisionPlace of publication
C/O Jeff Boatright, Lab B, 5500 Emory Eye Center, 1327 Clifton Rd, N E, Atlanta, USA, Ga, 30322Rights statement
Copyright 2015 The Authors-this work is distributed under the terms of a Creative Commons Attribution-NonCommercial-NoDerivatives License 3.0 (CC BY-NC-ND 3.0 AU). http://creativecommons.org/licenses/by-nc-nd/3.0/Repository Status
- Open
